Logo of Twareat Medical Co.
The Capital Market Authority (CMA) approved the application of Twareat Medical Co. to register its shares for direct listing on Nomu-Parallel Market.
Trading of these shares will be limited to qualified investors as defined in the glossary of terms used in the CMA’s regulations and rules.
According to the CMA, the registration document will be published sufficiently in advance of the listing date.
The approval of the application will be valid for six months from the CMA board resolution date.
Accordingly, the approval will be deemed cancelled if the target listing is not completed within this period, the statement said.
The company provides medical care services, including emergency medicine, radiology, dermatology, pediatrics, and others. Additionally, it offers educational and training courses for medical students and professionals. Al-Ahsa Development has owned a 25% stake in the company since the first half of 2019.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}